I think 2017 was another great year for Australian growth shares.

One of the key highlights was the performance of A2 Milk Company Ltd (ASX: A2M). Its bumper profit result has gone a long way to justifying its shares more than tripling in value this year.

I see no reason why Australian growth shares can’t continue this strong run next year. In light of this, below I have listed two shares which I think can beat the market in 2018:

Aristocrat Leisure Limited (ASX: ALL)

This gaming technology company is far more than meets the eye. Many investors will know of Aristrocrat Leisure as a designer and manufacturer of pokie machines, but that is only part of its business. The main attraction to the company in my opinion is its fast-growing digital segment. Thanks to a series of acquisitions the segment is poised to be its growth engine for the next decade. I’ve been very impressed at the recurring revenues the segment has generated and expect further strong growth in FY 2018.

CSL Limited (ASX: CSL)

While I wouldn’t necessarily expect this biotherapeutics company’s shares to perform as strongly as they did this year, I still believe they have the potential to outperform the market in 2018 and beyond due to the strong performance of its leading immunoglobulin business and soon to be profitable Seqirus vaccine business. Ultimately, I believe these businesses and the strong underlying demand it is experiencing has put the company in a position to deliver above-average long-term profit growth.